United States Pharmacopeia(USP) to set up a new
facility at the Genome Valley
Hyderabad|India|June '2011:
A delegation of United States Pharmacopeia (USP)
called on the Chief Minister Sri N.Kiran Kumar
Reddy and requested him to inaugurate their
Hyderabad facility in September, 2011.
The United States Pharmacopeia (USP), an official
public standards-setting authority for all
prescription and over-the-counter medicines and
other healthcare products, is setting up a new
facility at the Genome Valley (ICICI Knowledge
Park) on the outskirts of Hyderabad with an
investment of $15 million (approximately Rs.68
crore). Dr.K.V.Surendranath, Vice President of USP,
India Branch lead the delegation.
"The new 1,10,000-sft building that USP
constructing on 4.5- acre land will be the 'second
home'. The building is nearing completion.
The facility will be the largest site for USP
outside the US. It will house analytical research
and development, micro-biology, micro-analytical
and organic synthetic chemistry labs, besides
boosting facilities to conduct training
programmes. The organisation has been operating
from a 10,000-sft leased space in Hyderabad since
the last five years.
The objective behind expanding its India
operations is that Indian offered a lot of
opportunities for USP in many ways. They started
as a collaborative testing laboratory in
Hyderabad. Roughly 35 per cent of the drugs that
are imported into the US come from India. USP's
main customers (users) for its reference standards
and USP books are all in India, accounting for
10-12 per cent of the organisation's global
customers, Sri Surendranath said.
There was a natural synergy between USP and the
India pharmaceutical industry in the development
and establishment of public standards of the
latter's drugs, USP was expanding its
certification activities in the country, not just
for India but also involving several other
countries in the world. "Hyderabad will be their
central location for providing certification
services".
June.2011
